Olgu Sunumu

Outcomes of late endocrinologic evaluation in adult patients with thalassemia major: case series

Cilt: 49 Sayı: 3 30 Eylül 2024
PDF İndir
EN TR

Outcomes of late endocrinologic evaluation in adult patients with thalassemia major: case series

Abstract

AThalassemia is a group of inherited disorders characterized by the reduced or absent synthesis of the globin chains that make up hemoglobin. Transfusion-dependent thalassemia (TDT) is the most severe form, which requires lifelong transfusion. Complications related to the heart, liver and endocrine glands caused by the accumulation of excess iron in different organs due to transfusions are seen in adult patients. Of these complications, endocrine gland complications are widespread in adult patients. Hypogonadism is the most commonly reported endocrine complication, which affects 70-80% of thalassemia major patients. In this case series, we will present three female patients, aged 37, 18 and 27, who were followed up with the diagnosis of TDT and who underwent endocrinological evaluation in adulthood. We aim to emphasize that the diagnosis of hypogonadotropic hypogonadism and growth hormone (GH) deficiency was made late because the endocrinological evaluation of these patients was performed at an adult age, and we discussed the consequences of this. The survival of TDT patients has improved significantly in the last decade due to the introduction of transfusion, oral iron chelation therapies, and bone marrow transplantation, and these patients live into adulthood. Therefore, endocrinologic evaluation should be performed in pre-pubertal and pubertal periods. Early recognition of endocrine complications and early initiation of treatment are important to prevent irreversible sequelae.

Keywords

Thalassemia Major , hypogonadism , growth hormone deficiency

Kaynakça

  1. Weatherall DJ. Disorder of globin synthesis: the thalassemias. in Williams Hematology. 7th ed. (Eds MA Lichtman, E Beutler, TJ Kipps, U Seligsohn, K Kaushansky, JT Prchal):633-66. New York, McGraw-Hill, 2006.
  2. De Sanctis V, Soliman AT. ICET-A: An opportunity for improving thalassemia management. Journal of Blood Disorders. 2014;1:2.
  3. De Sanctis V, Elsedfy H, Soliman AT, Elhakim IZ, Soliman NA, Elalaily R et al. Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center. Indian J Endocrinol Metab. 2016;20:451-9.
  4. Oğuz SH, Okay M,Fedai AB et al. Endocrine disorders in adult beta-thalassemia patients:Insights from a long-term follow-up. Endocrinol Res Pract. 2023;27:205-12.
  5. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;21:11
  6. Srisukh S, Ongphiphadhanakul B, Bunnag P. Hypogonadism in thalassemia major patients. J Clin Transl Endocrinol. 2016;16:42-5.
  7. Chatterjee R, Katz M, Cox TF, Porter JB. Prospective study of the hypothalamic pituitary axis in thalassaemic patients who developed secondary amenorrhoea. Clin Endocrinol (Oxf). 1993;39:287–96.
  8. Noetzli LJ, Panigrahy A, Mittelman SD, Hyderi A, Dongelyan A, Coates TD et al. Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol. 2012;87:167-71.
  9. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol. 2007;62:138–42.
  10. Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005;74:93–100.

Kaynak Göster

MLA
Topuz, Emek, vd. “Outcomes of late endocrinologic evaluation in adult patients with thalassemia major: case series”. Cukurova Medical Journal, c. 49, sy 3, Eylül 2024, ss. 834-40, doi:10.17826/cumj.1405545.